Infectious Diseases
Infectious Disease research is a large, complex area often further complicated by the inclusion of immunocompromised critically ill patients.
We are committed to pushing innovative therapies through clinical development, and we specialize in hospitalized, complex, and critically ill populations.
Some of our adult and pediatric experience includes:
Specific Areas
- Adenovirus
- BK/Polyomavirus
- Coronavirus / COVID-19
- Cytomegalovirus (CMV)
- Fungal infections
- Aspergillosis
- Cryptococcus
- Histoplasmosis
- Hepatitis B virus (HBV)
- Hepatitis C virus (HCV)
- Hepatitis D virus (HDV)
- Herpes simplex virus (HSV)
- Human Papillomavirus (HPV)
- Meningitis
Immunocompromised Populations
- Hematopoietic stem cell transplantation (HSCT)
- Human immunodeficiency virus (HIV)
- Solid organ transplant (heart, kidney, liver, and pancreas)
- Oncology
We offer our sponsors:
- Experience in managing competitive enrollment
- A deep therapeutic expertise focused on complex and critically ill patient populations
- An employee turnover rate less than half of the reported industry average resulting in team continuity
- Experience with first-in-human, first-in-class, and first-in-patient trials
- Personal relationships with key investigators and site personnel
- Executive management involvement on every project
- CTI studies regularly exceed industry standards for enrollment, despite challenging patient populations
- A proven track record of success with more than 100 drug and device approvals